| Year |
Title |
Altmetric |
| 2019
|
The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.
Chemistry and Physics of Lipids.
219:28-35.
2019
|
|
| 2018
|
Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques.
Journal of Lipid Research.
59:2075-2083.
2018
|
|
| 2018
|
The apolipoprotein e mimetic peptide AEM-2 attenuates mitochondrial injury and apoptosis in human THP-1 macrophages.
Current topics in peptide & protein research.
19:15-25.
2018
|
|
| 2017
|
Cholesterol reduction and macrophage function: Role of paraoxonases.
Current Opinion in Lipidology.
28:397-402.
2017
|
|
| 2017
|
High-density lipoprotein regulation of mitochondrial function.
Advances in Experimental Medicine and Biology.
982:407-429.
2017
|
|
| 2016
|
Apolipoprotein mimetic peptides as modulators of lipoprotein function
2016
|
|
| 2016
|
High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms.
Chemistry and Physics of Lipids.
199:161-169.
2016
|
|
| 2016
|
Independent effects of early-life experience and trait aggression on cardiovascular function
2016
|
|
| 2015
|
Recent developments in modulating atherogenic lipoproteins.
Current Opinion in Lipidology.
26:369-375.
2015
|
|
| 2015
|
Bioenergetic programming of macrophages by the apolipoprotein A-I mimetic peptide 4F.
Biochemical Journal.
467:517-527.
2015
|
|
| 2015
|
Early changes in vascular reactivity in response to 56Fe irradiation in ApoE-/- mice.
Acta Astronautica.
108:40-45.
2015
|
|
| 2014
|
Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: A review.
Journal of Lipid Research.
55:2007-2021.
2014
|
|
| 2014
|
L-4F Inhibits Lipopolysaccharide-Mediated Activation of Primary Human Neutrophils.
Inflammation.
37:1401-1412.
2014
|
|
| 2014
|
Inhibitors of arachidonate-regulated calcium channel signaling suppress triggered activity induced by the late sodium current
2014
|
|
| 2013
|
Anti-Inflammatory Mechanisms of Apolipoprotein A-I Mimetic Peptide in Acute Respiratory Distress Syndrome Secondary to Sepsis.
PLoS ONE.
8.
2013
|
|
| 2012
|
Regulation of pattern recognition receptors by the apolipoprotein A-I mimetic peptide 4F
2012
|
|
| 2012
|
Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F.
Journal of Lipid Research.
53:1576-1587.
2012
|
|
| 2011
|
HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats..
Journal of Clinical and Experimental Cardiology.
2.
2011
|
|
| 2011
|
Acyloxy nitroso compounds as nitroxyl (HNO) donors: Kinetics, reactions with thiols, and vasodilation properties.
Journal of Medicinal Chemistry.
54:1059-1070.
2011
|
|
| 2010
|
ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity.
Advances in Experimental Medicine and Biology.
660:1-4.
2010
|
|
| 2010
|
The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.
Journal of Lipid Research.
51:2695-2705.
2010
|
|
| 2010
|
Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels.
Free Radical Biology and Medicine.
49:339-347.
2010
|
|
| 2010
|
Potential for chlorine gas-induced injury in the extrapulmonary vasculature.
Annals of the American Thoracic Society.
7:290-293.
2010
|
|
| 2010
|
Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages
2010
|
|
| 2010
|
Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH2.
Atherosclerosis.
208:134-141.
2010
|
|
| 2009
|
Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats
2009
|
|
| 2009
|
Pulmonary ozone exposure induces vascular dysfunction, mitochondrial damage, and atherogenesis
2009
|
|
| 2009
|
Protein O-GlcNAcylation: A new signaling paradigm for the cardiovascular system
2009
|
|
| 2009
|
Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.)..
Vascular Disease Prevention.
6:122-130.
2009
|
|
| 2008
|
HDL therapy for cardiovascular diseases: The road to HDL mimetics.
Current Atherosclerosis Reports.
10:405-412.
2008
|
|
| 2006
|
Atherosclerosis and vascular disease: Effects of peptide mimetics of apolilpoproteins.
Current Pharmaceutical Biotechnology.
7:235-240.
2006
|
|
| 2006
|
Synthetic peptides: Managing lipid disorders.
Current Opinion in Lipidology.
17:233-237.
2006
|
|
| 2005
|
Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats
2005
|
|
| 2005
|
Evidence of cardiovascular protection by moderate alcohol: Role of nitric oxide.
Free Radical Biology and Medicine.
39:540-548.
2005
|
|
| 2005
|
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide.
Circulation Research.
97:236-243.
2005
|
|
| 2005
|
Apolipoprotein E mimetic peptide dramatically lowers plasma cholesterol and restores endothelial function in Watanabe heritable hyperlipidemic rabbits.
Circulation.
111:3112-3118.
2005
|
|
| 2005
|
Assessing NO-dependent vasodilatation using vessel bioassays at defined oxygen tensions.
Methods in Enzymology.
396:553-568.
2005
|
|
| 2004
|
L-Arginine inhibits xanthine oxidase-dependent endothelial dysfunction in hypercholesterolemia.
FEBS Letters.
561:94-98.
2004
|
|
| 2003
|
Vasoactivity of S-nitrosohemoglobin: Role of oxygen, heme, and NO oxidation states.
Blood.
101:4408-4415.
2003
|
|
| 2003
|
The neointimal response ot endovascular injury is increased in obese Zucker rats
2003
|
|
| 2002
|
Nitrolinoleate, a nitric oxide-derived mediator of cell function: Synthesis, characterization, and vasomotor activity
2002
|
|
| 2002
|
Myeloperoxidase, a leukocyte-derived vascular NO oxidase.
Science.
296:2391-2394.
2002
|
|
| 2001
|
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
2001
|
|
| 2001
|
Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration..
Journal of Clinical Investigation.
108:1759-1770.
2001
|
|
| 2001
|
Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid.
2001
|
|
| 2001
|
L-Arginine Chlorination Products Inhibit Endothelial Nitric Oxide Production.
Journal of Biological Chemistry.
276:27159-27165.
2001
|
|
| 2001
|
Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid
2001
|
|
| 2001
|
Enhanced antioxidant activity after chlorination of quercetin by hypochlorous acid.
Alcoholism: Clinical and Experimental Research.
25:434-443.
2001
|
|
| 2001
|
Formation of novel bioactive metabolites from the reactions of pro-inflammatory oxidants with polyphenolics.
BioFactors.
15:79-81.
2001
|
|
| 2001
|
Human angiotensin II type 1 receptor isoforms encoded by messenger RNA splice variants are functionally distinct
2001
|
|
| 2000
|
Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats..
Hypertension.
35:403-408.
2000
|
|
| 1999
|
Chemiluminescent detection of oxidants in vascular tissue: Lucigenin but not coelenterazine enhances superoxide formation.
Circulation Research.
84:1203-1211.
1999
|
|
| 1999
|
Biological aspects of reactive nitrogen species
1999
|
|
| 1999
|
Nitric oxide donor generation from reactions of peroxynitrite.
Methods in Enzymology.
301:288-298.
1999
|
|
| 1998
|
Nitrosation of uric acid by peroxynitrite: Formation of a vasoactive nitric oxide donor.
Journal of Biological Chemistry.
273:24491-24497.
1998
|
|
| 1998
|
Captopril treatment and its withdrawal prevents impairment of endothelium-dependent responses in the spontaneously hypertensive rat.
Clinical and experimental hypertension.
20:847-866.
1998
|
|
| 1997
|
No role for NO in estrogen-mediated vasoprotection?.
Circulation.
96:2769-2771.
1997
|
|
| 1997
|
Formation of the NO donors glyceryl mononitrate and glyceryl mononitrite from the reaction of peroxynitrite with glycerol.
Biochemical Journal.
328:517-524.
1997
|
|
| 1997
|
Estrogen restores endothelial cell function in an experimental model of vascular injury.
Circulation.
96:1624-1630.
1997
|
|
| 1997
|
Immunoglobulin light chain alters mesangial cell calcium homeostasis..
American Journal of Physiology.
272:F319-F324.
1997
|
|
| 1997
|
Gender and cardiovascular disease: Recent insights.
Trends in Cardiovascular Medicine.
7:94-100.
1997
|
|
| 1997
|
Immunoglobulin light chain alters mesangial cell calcium homeostasis
1997
|
|
| 1997
|
Nitric oxide, free radicals and cell signalling in cardiovascular disease.
Biochemical Society Transactions.
25.
1997
|
|
| 1997
|
The interplay of nitric oxide and peroxynitrite with signal transduction pathways: Implications for disease.
Seminars in Perinatology.
21:351-366.
1997
|
|
| 1996
|
Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits
1996
|
|
| 1995
|
A functional comparison of the rat type-1 angiotensin II receptors (AT1AR and AT1BR).
Regulatory Peptides.
60:135-147.
1995
|
|
| 1995
|
Calcium-Sensitive Chloride Channels in Vascular Smooth Muscle Cells
1995
|
|
| 1995
|
Hyperglycemia alters cytoplasmic Ca2+ responses to capacitative Ca2+ influx in rat aortic smooth muscle cells
1995
|
|
| 1995
|
Oxygen Radical-Nitric Oxide Reactions in Vascular Diseases.
Advances in Pharmacology.
34:45-69.
1995
|
|
| 1994
|
Calcium-mobilizing agonists stimulate anion fluxes in cultured endothelial cells from human umbilical vein
1994
|
|
| 1994
|
Superoxide and peroxynitrite in atherosclerosis
1994
|
|
| 1994
|
Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry..
Biological chemistry Hoppe-Seyler.
375:81-88.
1994
|
|
